<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02745171</url>
  </required_header>
  <id_info>
    <org_study_id>50967815.7.0000.5208</org_study_id>
    <nct_id>NCT02745171</nct_id>
  </id_info>
  <brief_title>Continuous Behavior Assessment of the Effects of a Physical Therapy Program for Patients With Parkinson's Disease</brief_title>
  <official_title>Continuous Behavior Assessment of the Effects of a Physical Therapy Program for Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Pernambuco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal de Pernambuco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Parkinson's disease (PD) results from dysfunction of the dopaminergic system of
      degenerative and progressive, with changes in the nigrostriatal pathway, and decreased
      concentration of dopamine. Has as clinical signs, symptoms called cardinal engines: resting
      tremor, bradykinesia, rigidity and postural instability. In addition to drug therapy,
      physical therapy is also considered a useful tool for the treatment of motor disorders of the
      disease. The role of physiotherapy aims to stimulate the security and independence of
      patients with PD in carrying out activities and to preserve and improve physical function.
      Some studies have shown the negative effect of the disease on quality of life and functional
      mobility. Few studies have been conducted to evaluate the effects of long-term therapy in PD,
      but many report the beneficial effects of a rehabilitation program in a short period of time.

      Objective: To continually assess the effects after the completion of a physical therapy
      program in patients with Parkinson's disease.

      Methods: Type study randomized double blind clinical trial in Parkinson Pro Program Hospital
      of the Federal University of Pernambuco. Will be recruited subjects with PD, both sexes, in
      stages 1 to 3 on the scale of Hoehn Yahr and score greater than 18 on the Mini-Mental.
      Patients who are recruited will undergo an assessment using the scales of assessment of
      functional mobility, quality of life and motor examination before starting physical therapy
      at the end of treatment and two months after completion of treatment, and the intervals
      assessments of a month.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Parkinson's disease results from dysfunction of the dopaminergic systems, cholinergic,
      serotonergic and noradrenergic, though the neuropathological basic pattern is the change of
      the nigrostriatal pathway, with decreased concentration of dopamine at the level of dopamine
      receptors in the body striatum.

      With still little known etiology in most instances, the Parkinson's disease has as clinical
      signs, symptoms called cardinal engines: resting tremor, bradykinesia, rigidity and postural
      instability. Additionally, patients may exhibit cognitive deficits and emotional changes with
      the progression of the disease.

      The clinical diagnosis is primarily based on the identification of the cardinal motor
      symptoms plus the initial response to levodopa therapy . The literature is unanimous in
      admitting that the use of Levodopa (L-dopa) is the most effective drug for the treatment, and
      its administration the most recommended in satisfactory symptom control.

      In addition to drug therapy, physical therapy is also considered a useful tool for the
      treatment of motor disorders associated disease. Although the speed of the motor of the
      patient learningParkinson's disease is lower than their control group of the same age,
      rehabilitation, these individuals may also acquire motor skills as well as improve their
      performance through practice repetition.

      Although a physical rehabilitation program to be beneficial to improve the activities of
      daily living (ADL) and mobility in patients with Parkinson's disease , it is not yet clear
      how long its effect is sustained. Most clinical trials of physiotherapy in PD were based on
      short-term rehabilitation programs.

      Few studies have been conducted to evaluate the effects of long-term physical therapy in
      Parkinson's disease, but many report the beneficial effects of a short-term rehabilitation
      program, without having to concern monitoring after the physical therapy.

      Thus this study aims to continuously evaluate the behavior of the effects of a physical
      therapy program in patients with Parkinson's disease.

      Knowledge of the time interval which is the decline of the gains from physiotherapy is a
      guiding point to guide the patient regarding their return to service for revaluation, also
      considering the fact that the disease have progressive.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from quality of life</measure>
    <time_frame>change in quality of life, it is evaluated every month to complete the four-month period.</time_frame>
    <description>The PDQ-39 is a specific rating scale of QOL in PD and comprises 39 items that can be answered with five different response options: &quot;never&quot;; &quot;On occasion&quot;; &quot;sometimes&quot;; &quot;often&quot;; &quot;Always&quot; or &quot;it is impossible for me.&quot;</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will be evaluated after three months there will be a reassessment, in this case the participating subjects do not perform any kind of therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There will be an initial evaluation, after a month of physical therapy at the end of the protocol, and twice more after the protocol, both interval a month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>physical therapy</intervention_name>
    <description>Will be held 15 sessions, 2 times a week, lasting 50 minutes, a physical therapy protocol developed by the Pro-Parkinson Physiotherapy based on the Guide of the Dutch Society of Physiotherapy (Keus, 2004).</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients diagnosed with Idiopathic Parkinson's disease according to the Bank of London
             Brain (Hughes et al, 1992);

          2. Both sexes;

          3. Patients in stages 1 through 3 for this modified version of the Hoehn &amp; Yahr scale
             (HY);

          4. the patient Agreement to participate in the research after explanation and
             understanding of it and signing the Consent and Informed.

        Exclusion Criteria:

          1. cognitive disorder identified by the Mini-Mental State Examination as schooling ;

          2. Patients with other neurological diseases;

          3. initiate other rehabilitative treatment throughout and after the physical therapy
             program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria G Coriolano</last_name>
    <phone>(81)984768060</phone>
    <email>gracawander@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universidade Federal de Pernambuco</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50670-901</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruna P Prudente</last_name>
      <phone>(81)99728-0870</phone>
      <email>brubrupp@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2016</study_first_submitted>
  <study_first_submitted_qc>April 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2016</study_first_posted>
  <last_update_submitted>April 19, 2016</last_update_submitted>
  <last_update_submitted_qc>April 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Pernambuco</investigator_affiliation>
    <investigator_full_name>MARIA DAS GRAÃ‡AS WANDERLEY DE SALES CORIOLANO</investigator_full_name>
    <investigator_title>Associate Professor Department of Anatomy at UFPE</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Functional mobility</keyword>
  <keyword>Follow up</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

